Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON42020
NL-OMON42020
Completed
Not Applicable

Observational prospective study to evaluate the efficacy of Vitamin K Intravenously on the coagulopathy in patients with peroxisomal biogenesis disorders (PBD) - VitKId

Kinderhematologie0 sites5 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscongenital metabolic diseasesPeroxisomal biogenesis disorderzellweger syndrome spectrum1006447710021605

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
congenital metabolic diseases
Sponsor
Kinderhematologie
Enrollment
5
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Kinderhematologie

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with PBD over five years of age
  • •2\. Coagulopathy with prolonged PT, low FVII concentration and increased
  • •PIVKA level due to vitamin K deficiency.

Exclusion Criteria

  • •1\. No oral or written informed consent of the parents.
  • •2\. No coagulopathy as measured by PT.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Role of transcutaneous nerve stimulation at external ear for pain relief and haemodynamic stability of heart surgery patientHealth Condition 1: I089- Rheumatic multiple valve disease,unspecified
CTRI/2020/05/025464SGPGIMS Lucknow
Recruiting
Not Applicable
Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstructioNeoplasms
KCT0008722Asan Medical Center50
Recruiting
Not Applicable
ong delayed emesis induced by cancer chemotherapy can be suppressed by NK1 receptor antagonist (LODEC-N)
JPRN-jRCT1030230130Seiichiro Kuroda100
Recruiting
Not Applicable
Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B)on-small cell lung cancer
JPRN-UMIN000050878orth East Japan Study Group (NEJSG)135
Completed
Not Applicable
Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysisung Cancer
JPRN-UMIN000029995ational Cancer CEnter200